Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis.

Bajic JE, Eden GL, Lampton LS, Cheah KY, Lymn KA, Pei JV, Yool AJ, Howarth GS.

World J Gastroenterol. 2016 Oct 7;22(37):8322-8333.

2.
3.

Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer.

Strizich G, Gammon MD, Jacobson JS, Wall M, Abrahamson P, Bradshaw PT, Terry MB, Teitelbaum S, Neugut AI, Greenlee H.

BMC Complement Altern Med. 2015 Nov 19;15:411. doi: 10.1186/s12906-015-0937-4.

4.

A Study on the Characteristics of Infrequent and Frequent Outpatients Visiting Korean Traditional Medical Facilities.

Yoon J, Park H, Chu C, Choi SY, Lee K, Lee S.

Osong Public Health Res Perspect. 2015 Jun;6(3):170-83. doi: 10.1016/j.phrp.2015.06.001. Epub 2015 Jun 5.

5.

An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits.

Koenig CJ, Ho EY, Trupin L, Dohan D.

Patient Educ Couns. 2015 Jul;98(7):857-63. doi: 10.1016/j.pec.2015.02.018. Epub 2015 Mar 14.

6.

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D; Society for Integrative Oncology.

J Natl Cancer Inst Monogr. 2014 Nov;2014(50):346-58. doi: 10.1093/jncimonographs/lgu041. Review. Erratum in: J Natl Cancer Inst Monogr. 2015 May;2015(51):98.

7.

Evaluation of effectiveness of herbal medication in cancer care: a review study.

Tavakoli J, Miar S, Majid Zadehzare M, Akbari H.

Iran J Cancer Prev. 2012 Summer;5(3):144-56. Review.

8.

Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication.

Sohl SJ, Borowski LA, Kent EE, Smith AW, Oakley-Girvan I, Rothman RL, Arora NK.

Cancer. 2015 Mar 15;121(6):900-7. doi: 10.1002/cncr.29138. Epub 2014 Nov 11.

9.

Pharmacists' knowledge and attitudes about natural health products: a mixed-methods study.

Kheir N, Gad HY, Abu-Yousef SE.

Drug Healthc Patient Saf. 2014 Jan 30;6:7-14. doi: 10.2147/DHPS.S57756. eCollection 2014.

10.

A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine.

Parker PA, Urbauer D, Fisch MJ, Fellman B, Hough H, Miller J, Lanzotti V, Whisnant M, Weiss M, Fellenz L, Bury M, Kokx P, Finn K, Daily M, Cohen L.

Cancer. 2013 Oct 1;119(19):3514-22. doi: 10.1002/cncr.28240. Epub 2013 Jul 3.

11.

Complementary and alternative medicine use among patients with thyroid cancer.

Rosen JE, Gardiner P, Saper RB, Filippelli AC, White LF, Pearce EN, Gupta-Lawrence RL, Lee SL.

Thyroid. 2013 Oct;23(10):1238-46. doi: 10.1089/thy.2012.0495. Epub 2013 Jul 25.

12.

Supplement use during an intergroup clinical trial for breast cancer (S0221).

Zirpoli GR, Brennan PM, Hong CC, McCann SE, Ciupak G, Davis W, Unger JM, Budd GT, Hershman DL, Moore HC, Stewart J, Isaacs C, Hobday T, Salim M, Hortobagyi GN, Gralow JR, Albain KS, Ambrosone CB.

Breast Cancer Res Treat. 2013 Feb;137(3):903-13. doi: 10.1007/s10549-012-2400-2. Epub 2013 Jan 10.

13.

Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Davis EL, Oh B, Butow PN, Mullan BA, Clarke S.

Oncologist. 2012;17(11):1475-81. doi: 10.1634/theoncologist.2012-0223. Epub 2012 Aug 29. Review.

14.

Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Standish LJ, Sweet E, Naydis E, Andersen MR.

Integr Cancer Ther. 2013 Mar;12(2):126-35. doi: 10.1177/1534735412447582. Epub 2012 Jun 27.

15.

Determination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use.

Mayadagli A, Aksu A, Goksel F, Gocen E, Karahacioglu E, Gumus M, Pak Y.

Afr J Tradit Complement Altern Med. 2011;8(4):477-82. Epub 2011 Jun 1.

16.

Use of Chinese medicine by cancer patients: a review of surveys.

Carmady B, Smith CA.

Chin Med. 2011 Jun 9;6:22. doi: 10.1186/1749-8546-6-22.

17.

Classification of CAM use and its correlates in patients with early-stage breast cancer.

Saquib J, Madlensky L, Kealey S, Saquib N, Natarajan L, Newman VA, Patterson RE, Pierce JP.

Integr Cancer Ther. 2011 Jun;10(2):138-47. doi: 10.1177/1534735410392578. Epub 2011 Mar 7.

18.

Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Gulluoglu BM, Cingi A, Cakir T, Barlas A.

Breast Care (Basel). 2008;3(4):269-273. Epub 2008 Aug 11.

19.

Predictors of yoga use among patients with breast cancer.

Desai K, Bowman MA, Galantino ML, Hughes-Halbert C, Vapiwala N, Demichele A, Mao JJ.

Explore (NY). 2010 Nov-Dec;6(6):359-63. doi: 10.1016/j.explore.2010.08.002.

20.

Complementary and alternative medicine use among cancer survivors: a population-based study.

Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J.

J Cancer Surviv. 2011 Mar;5(1):8-17. doi: 10.1007/s11764-010-0153-7. Epub 2010 Oct 6.

Supplemental Content

Support Center